scholarly article | Q13442814 |
P356 | DOI | 10.1097/SLA.0B013E31816FFAB6XXX |
P698 | PubMed publication ID | 18520234 |
P2093 | author name string | Chung Mau Lo | |
Sheung Tat Fan | |||
Kwan Man | |||
Qiao Cheng | |||
Kevin T Ng | |||
Irene O Ng | |||
Chris K Sun | |||
Jiang Wei Xiao | |||
Bai Shun Sun | |||
P2860 | cites work | Rapamycin attenuates liver graft injury in cirrhotic recipient--the significance of down-regulation of Rho-ROCK-VEGF pathway | Q56750684 |
P433 | issue | 6 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | liver transplantation | Q1368191 |
neoplastic invasiveness | Q112498967 | ||
P304 | page(s) | 1049-1057 | |
P577 | publication date | 2008-06-01 | |
P1433 | published in | Annals of Surgery | Q4767866 |
P1476 | title | The significance of acute phase small-for-size graft injury on tumor growth and invasiveness after liver transplantation | |
P478 | volume | 247 |
Q26749857 | A review of current status of living donor liver transplantation |
Q37636484 | Beyond Milan criteria--chances and risks of expanding transplantation criteria for HCC patients with liver cirrhosis |
Q48106523 | Does the Pringle maneuver affect survival and recurrence following surgical resection for hepatocellular carcinoma? A western series of 441 patients |
Q90236683 | Does the intermittent Pringle maneuver affect the recurrence following surgical resection for hepatocellular carcinoma? A systematic review |
Q41002670 | Donor miR-196a-2 polymorphism is associated with hepatocellular carcinoma recurrence after liver transplantation in a Han Chinese population |
Q48329517 | Dynamic Volume Assessment of Hepatocellular Carcinoma in Rat Livers Using a Clinical 3T MRI and Novel Segmentation. |
Q37190186 | Early-phase circulating miRNAs predict tumor recurrence and survival of hepatocellular carcinoma patients after liver transplantation. |
Q28651675 | Effect of liver regeneration on malignant hepatic tumors |
Q34365785 | Effect of the pringle maneuver on tumor recurrence of hepatocellular carcinoma after curative resection (EPTRH): a randomized, prospective, controlled multicenter trial |
Q34182635 | FTY720 suppresses liver tumor metastasis by reducing the population of circulating endothelial progenitor cells |
Q34764430 | Genomic predictors for recurrence patterns of hepatocellular carcinoma: model derivation and validation |
Q47114724 | Glutathione Peroxidase 3 Delivered by hiPSC-MSCs Ameliorated Hepatic IR Injury via Inhibition of Hepatic Senescence |
Q39548324 | Growth of hepatocellular carcinoma in the regenerating liver |
Q34610682 | Impact of hepatic arterial reconstruction on orthotopic liver transplantation in the rat. |
Q26766049 | Impact of non-oncological factors on tumor recurrence after liver transplantation in hepatocellular carcinoma patients |
Q40597524 | Impact of operative and peri-operative factors on the long-term prognosis of primary liver cancer patients undergoing hepatectomy |
Q33710669 | Inhibition of transforming growth factor-beta/Smad signaling improves regeneration of small-for-size rat liver grafts |
Q41017463 | Interferon-gamma inducible protein 10 (IP10) induced cisplatin resistance of HCC after liver transplantation through ER stress signaling pathway |
Q36154069 | Intermittent hepatic inflow occlusion during partial hepatectomy for hepatocellular carcinoma does not shorten overall survival or increase the likelihood of tumor recurrence |
Q36962089 | Liver Transplantation for Hepatocellular Carcinoma beyond Milan Criteria: Multidisciplinary Approach to Improve Outcome |
Q89953527 | Living vs. deceased-donor liver transplantation for patients with hepatocellular carcinoma |
Q34263346 | Living-donor vs deceased-donor liver transplantation for patients with hepatocellular carcinoma |
Q40778578 | Longer duration of the Pringle maneuver is associated with hepatocellular carcinoma recurrence following curative resection |
Q40235716 | Postoperative peak serum C-reactive protein is a predictor of outcome following liver transplantation for hepatocellular carcinoma |
Q37972812 | Prognostic indicators for tumor recurrence after liver transplantation in hepatocellular carcinoma and related molecular targeted therapy |
Q45789352 | Protective effects of simultaneous splenectomy on small-for-size liver graft injury in rat liver transplantation |
Q37317375 | Repressor and activator protein accelerates hepatic ischemia reperfusion injury by promoting neutrophil inflammatory response |
Q34264788 | Salvage liver transplantation is a reasonable option for selected patients who have recurrent hepatocellular carcinoma after liver resection |
Q47189438 | Small-for-size grafts increase recurrence of hepatocellular carcinoma in liver transplantation beyond milan criteria |
Q37614646 | Small-for-size liver graft injury--impact on tumor behavior. |
Q36937325 | Smaller grafts do not imply early recurrence in recipients transplanted for hepatocellular carcinoma: A Chinese experience |
Q54989355 | Surgical Treatment of Hepatocellular Carcinoma. |
Q27300764 | The Clinical Significance and Potential Therapeutic Role of GPx3 in Tumor Recurrence after Liver Transplantation. |
Q50763246 | The impact of posthepatectomy liver failure on the recurrence of hepatocellular carcinoma. |
Q38259414 | The role of adult living donor liver transplantation and recent advances |
Q52593728 | Transcriptome Analysis of Acute Phase Liver Graft Injury in Liver Transplantation. |
Search more.